Stock Events

Stock Events

Bausch + Lomb 

€15.40
0
+€0.10+0.65% Friday 06:03

Statistics

Day High
15.4
Day Low
15.4
52W High
15.7
52W Low
12.3
Volume
0
Avg. Volume
0
Mkt Cap
5.5B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q1 2026
Q2 2026
Next
0.04
0.09
0.13
0.18
Expected EPS
0.17849925789
Actual EPS
N/A

Financials

-7.27%Profit Margin
Unprofitable
2021
2022
2023
2024
2025
4.42BRevenue
-321.84MNet Income

Analyst Ratings

15.43Average Price Target
The highest estimate is 17.45.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow S2L.MU. It's not an investment recommendation.
Amazon
7
AMZN
Alphabet
7
GOOGL
Apple
6
AAPL
Tesla
6
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson operates in the healthcare sector, offering a wide range of products including vision care products that compete directly with Bausch + Lomb's eye health products.
Novartis
NVS
Mkt Cap304.1B
Novartis, through its Alcon eye care division, provides products and equipment for eye care professionals and patients, directly competing with Bausch + Lomb's offerings.
Cooper Companies
COO
Mkt Cap13.57B
The Cooper Companies operate in the medical device sector, focusing on contact lens and women's health, making it a direct competitor in the vision care market.
Alcon
ALC
Mkt Cap34.08B
Alcon focuses on eye care products ranging from surgical devices to contact lenses, competing across several of Bausch + Lomb's key product areas.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie, through its acquisition of Allergan, has a strong presence in the eye care market, particularly in treatments for conditions like dry eye, directly competing with Bausch + Lomb.
Staar Surgical
STAA
Mkt Cap1.18B
STAAR Surgical specializes in ophthalmic products, particularly implantable lenses, which competes with Bausch + Lomb's surgical products.
Eco Science Solutions
ESSI
Mkt Cap26,479
EssilorLuxottica is a leader in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, competing with Bausch + Lomb's vision care products.
Resmed
RMD
Mkt Cap32.94B
ResMed, while primarily focused on sleep apnea and respiratory conditions, also offers products in the health sector that can indirectly compete with Bausch + Lomb's broader healthcare offerings.

About

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Show more...
CEO
Brenton L. Saunders
Employees
13000
Country
Canada
ISIN
CA0717051076
WKN
000A3DLMS

Listings

STU
DE
S2L.STU
F
DE
S2L.F
MU
DE
S2L.MU
XNYS
US
BLCO

0 Comments

Share your thoughts

FAQ

What is Bausch + Lomb stock price today?▼
The current price of S2L.MU is €15.40 EUR — it has increased by +0.65% in the past 24 hours. Watch Bausch + Lomb stock price performance more closely on the chart.
What is Bausch + Lomb stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Bausch + Lomb stocks are traded under the ticker S2L.MU.
Is Bausch + Lomb stock price growing?▼
S2L.MU stock has risen by +3.36% compared to the previous week, the month change is a +8.45% rise, over the last year Bausch + Lomb has showed a +20.31% increase.
What is Bausch + Lomb market cap?▼
Today Bausch + Lomb has the market capitalization of 5.5B
When is the next Bausch + Lomb earnings date?▼
Bausch + Lomb is going to release the next earnings report on November 04, 2026.
What were Bausch + Lomb earnings last quarter?▼
S2L.MU earnings for the last quarter are 0.13 EUR per share, whereas the estimation was 0.13 EUR resulting in a -2.82% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Bausch + Lomb revenue for the last year?▼
Bausch + Lomb revenue for the last year amounts to 4.42B EUR.
What is Bausch + Lomb net income for the last year?▼
S2L.MU net income for the last year is -321.84M EUR.
How many employees does Bausch + Lomb have?▼
As of September 08, 2026, the company has 13,000 employees.
In which sector is Bausch + Lomb located?▼
Bausch + Lomb operates in the Health & Wellness sector.
When did Bausch + Lomb complete a stock split?▼
Bausch + Lomb has not had any recent stock splits.
Where is Bausch + Lomb headquartered?▼
Bausch + Lomb is headquartered in VAUGHAN, Canada.